title: Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure.
abstract: Pharmacologic activation of the heterodimeric HIF transcription factor appears promising as a strategy to treat diseases, such as anemia, myocardial infarction, and stroke, in which tissue hypoxia is a prominent feature. HIF accumulation is normally linked to oxygen availability because an oxygen-dependent posttranslational modification (prolyl hydroxylation) marks the HIFalpha subunit for polyubiquitination and destruction. Three enzymes (PHD1, PHD2, and PHD3) capable of catalyzing this reaction have been identified, although PHD2 (also called Egln1) appears to be the primary HIF prolyl hydroxylase in cell culture experiments. We found that conditional inactivation of PHD2 in mice is sufficient to activate a subset of HIF target genes, including erythropoietin, leading to striking increases in red blood cell production. Mice lacking PHD2 exhibit premature mortality associated with marked venous congestion and dilated cardiomyopathy. The latter is likely the result of hyperviscosity syndrome and volume overload, although a direct effect of chronic, high-level HIF stimulation on cardiac myocytes cannot be excluded.
authors: Department of Medical Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
authors: Yoji Andrew
authors: YA
authors: Minamishima
authors: Javid
authors: J
authors: Moslehi
authors: Nabeel
authors: N
authors: Bardeesy
authors: Darragh
authors: D
authors: Cullen
authors: Roderick T
authors: RT
authors: Bronson
authors: William G
authors: WG
authors: Kaelin
mesh_terms: D000483:Alleles; D000818:Animals; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D004452:Echocardiography; D004789:Enzyme Activation; D004920:Erythropoiesis / Q000235:genetics; D015971:Gene Expression Regulation, Enzymologic; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000201:enzymology* / Q000235:genetics*; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases; D017874:Immediate-Early Proteins / Q000235:genetics* / Q000378:metabolism*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010641:Phenotype; D011086:Polycythemia / Q000201:enzymology* / Q000235:genetics* / Q000473:pathology; D011393:Procollagen-Proline Dioxygenase; D012333:RNA, Messenger / Q000235:genetics
chemical_list: D004268:DNA-Binding Proteins; D017874:Immediate-Early Proteins; D012333:RNA, Messenger; D011393:Procollagen-Proline Dioxygenase; C490189:Egln1 protein, mouse; D064799:Hypoxia-Inducible Factor-Proline Dioxygenases